Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Amyloid-beta and tau protein beyond Alzheimer’s disease
Morteza Abyadeh, Vivek Gupta, João A. Paulo, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1262-1276
Open Access | Times Cited: 39
High-Intensity Interval Training Ameliorates Molecular Changes in the Hippocampus of Male Rats with the Diabetic Brain: the Role of Adiponectin
Kayvan Khoramipour, Mohammad Abbas Bejeshk, Mohammad Amin Rajizadeh, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 6, pp. 3486-3495
Open Access | Times Cited: 28
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Jangampalli Adi Pradeepkiran, Javaria Baig, Md Ariful Islam, et al.
Aging and Disease (2024)
Open Access | Times Cited: 15
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study
Mar Garcia-Zamora, Gemma García‐Lluch, Lucrecia Moreno, et al.
Pharmacological Research (2024) Vol. 206, pp. 107295-107295
Open Access | Times Cited: 15
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 9
High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction
Minli Qu, L. Zuo, Mengru Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 14
Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study
Myuri Ruthirakuhan, Walter Swardfager, Lisa Y. Xiong, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2766-2778
Open Access | Times Cited: 6
Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
Desh Deepak Singh, Ali A. Shati, Mohammad Y. Alfaifi, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3767-3767
Open Access | Times Cited: 20
Developing Non-Invasive Molecular Markers for Early Risk Assessment of Alzheimer's Disease
Tapas Kumar Sur, Tanmoy Mondal, Zarish Noreen, et al.
Biomarkers in Neuropsychiatry (2025), pp. 100120-100120
Open Access
The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias
Chuyao Huang, Zhenwen Wei, Ningxiang Zheng, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
Distinct factors drive the progression of tau pathology in Alzheimer's disease
Yifan Luo, Honglu Yu, Keqiang Ye
Fundamental Research (2025)
Open Access
Experimental and computational analyses of the anti-alzheimer and antidiabetic effects of flavonoid-rich extract of avocado seeds (Persea americana Mill.)
Oluwafemi Adeleke Ojo, Tobiloba Christiana Maduakolam-Aniobi, Gideon Ampoma Gyebi, et al.
Nutrire (2025) Vol. 50, Iss. 1
Closed Access
Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction
Xiangkuan Meng, Haiyang Du, Danpei Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
Chromogranin A deficiency attenuates tauopathy by altering epinephrine–alpha-adrenergic receptor signaling in PS19 mice
Suborno Jati, Daniel Muñoz-Mayorga, Shandy Shahabi, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer’s Disease
Margrethe A. Olesen, Rodrigo A. Quintanilla
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5691-5707
Closed Access | Times Cited: 9
Lipidized analogues of the anorexigenic CART (cocaine- and amphetamine-regulated transcript) neuropeptide show anorexigenic and neuroprotective potential in mouse model of monosodium-glutamate induced obesity
Vilém Charvát, Anna Strnadová, Aneta Myšková, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176864-176864
Open Access | Times Cited: 2
Emerging Gene Therapies for Alzheimer’s and Parkinson’s Diseases: An Overview of Clinical Trials and Promising Candidates
Will S Roberts, Shawn Price, Michael Wu, et al.
Cureus (2024)
Open Access | Times Cited: 2
Glyoxalase 1 overexpression improves neurovascular coupling and limits development of mild cognitive impairment in a mouse model of type 1 diabetes
Eline Berends, Margarita G. Pencheva, Marjo P. H. van de Waarenburg, et al.
The Journal of Physiology (2024) Vol. 602, Iss. 22, pp. 6209-6223
Open Access | Times Cited: 2
High sensitivity C-reactive protein and glycated hemoglobin levels as dominant predictors of all-cause dementia: a nationwide population-based cohort study
Yen‐Chun Fan, Chia‐Chi Chou, Bagas Suryo Bintoro, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9
“Adjust Zang and arouse spirit” electroacupuncture ameliorates cognitive impairment by reducing endoplasmic reticulum stress in db/db mice
Mengyuan Li, Yao Lin, Min He, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Exploring the Therapeutic Potential of DPP4 Inhibitors in Alzheimer's Disease: Molecular Insight and Clinical Outcome
Albert Joseph Sulangi, Sarah E. Lyons, Ahmed Ms Abdou, et al.
Cureus (2024)
Open Access | Times Cited: 1
Insulin Resistance Develops Due to an Imbalance in the Synthesis of Cyclic AMP and the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP)
H.K. Wasner
Stresses (2023) Vol. 3, Iss. 4, pp. 762-772
Open Access | Times Cited: 3
Can Alzheimer's Disease Be Secondary to Type-2 Diabetes Mellitus?
Vani Jangra, Jeshnu Tople
Cureus (2022)
Open Access | Times Cited: 4
Cognitive status and its risk factors in patients with hypertension and diabetes in a low‐income rural area of China: A cross‐sectional study
Yuyan Guo, Ruifeng Liang, Jingjuan Ren, et al.
International Journal of Geriatric Psychiatry (2023) Vol. 38, Iss. 10
Open Access | Times Cited: 1
Impact of Diabetes, Depression in Dementia
Arubala P. Reddy
American Journal of Biomedical Science & Research (2024) Vol. 21, Iss. 1, pp. 95-98
Open Access
Page 1 - Next Page

Scroll to top